« How to write a better extortion virus | Main | On the morality of not working on life extension »
June 5, 2006
Followup on Tysabri
The FDA has followed up on its committee's recommendation and decided to allow Tysabri to return to market. For those who just tuned in, Tysabri appears to be an unusually effective MS drug with a rare but nasty side effect--risk of death from a brain infection called PML. This seems like a good thing, but as I argued earlier, it would have been even better to have let people make their own decisions rather than have the FDA make some global cost/benefit decision.Posted by ekr at June 5, 2006 11:19 AM | Filed under: